BR112017013423A2 - métodos de cultura de célula de mamífero . - Google Patents

métodos de cultura de célula de mamífero .

Info

Publication number
BR112017013423A2
BR112017013423A2 BR112017013423A BR112017013423A BR112017013423A2 BR 112017013423 A2 BR112017013423 A2 BR 112017013423A2 BR 112017013423 A BR112017013423 A BR 112017013423A BR 112017013423 A BR112017013423 A BR 112017013423A BR 112017013423 A2 BR112017013423 A2 BR 112017013423A2
Authority
BR
Brazil
Prior art keywords
mammalian cell
cell culture
culture methods
concentration
liquid medium
Prior art date
Application number
BR112017013423A
Other languages
English (en)
Other versions
BR112017013423B1 (pt
Inventor
Cheng Cheng
Hwang Christopher
WALTHER Jason
Wang Jonathan
SHAH Neha
Bae Seul-A
Johnson Timothy
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of BR112017013423A2 publication Critical patent/BR112017013423A2/pt
Publication of BR112017013423B1 publication Critical patent/BR112017013423B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0681Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0043Medium free of human- or animal-derived components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/005Protein-free medium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2465Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/50Soluble polymers, e.g. polyethyleneglycol [PEG]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01022Alpha-galactosidase (3.2.1.22)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

a presente invenção refere-se aos métodos de cultura de uma célula de mamífero em um meio líquido incluindo poloxâmero-188 a uma concentração de 1,8 g / l, ou a uma concentração maior do que 1,8 g / l, ou um meio líquido que inclui uma concentração de poloxâmero-188, que é selecionada com base em um ou mais fatores selecionados a partir do grupo de: tamanho de poro, tipo de poro, taxa de fluxo de gás, densidade de célula viável no meio e marcadores relacionados ao estresse de célula.
BR112017013423-3A 2014-12-22 2015-12-21 Métodos para cultivo de célula de mamífero BR112017013423B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462095734P 2014-12-22 2014-12-22
US62/095,734 2014-12-22
PCT/US2015/067040 WO2016106192A2 (en) 2014-12-22 2015-12-21 Methods of culturing a mammalian cell

Publications (2)

Publication Number Publication Date
BR112017013423A2 true BR112017013423A2 (pt) 2018-01-09
BR112017013423B1 BR112017013423B1 (pt) 2023-04-11

Family

ID=55527619

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017013423-3A BR112017013423B1 (pt) 2014-12-22 2015-12-21 Métodos para cultivo de célula de mamífero

Country Status (15)

Country Link
US (2) US11306341B2 (pt)
EP (1) EP3237604A2 (pt)
JP (4) JP6843750B2 (pt)
KR (2) KR20230125102A (pt)
CN (1) CN107567495A (pt)
AU (2) AU2015369809B2 (pt)
BR (1) BR112017013423B1 (pt)
CA (2) CA3225136A1 (pt)
HK (1) HK1246345A1 (pt)
IL (2) IL253071B2 (pt)
MX (2) MX2017008338A (pt)
RU (1) RU2712746C2 (pt)
SG (2) SG10202001034PA (pt)
TW (2) TWI741851B (pt)
WO (1) WO2016106192A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2901940A1 (en) 2013-02-22 2014-08-28 Genzyme Corporation Microcarrier perfusion culturing methods and uses thereof
AU2014218723B2 (en) 2013-02-22 2019-12-05 Genzyme Corporation Microcarrier perfusion culturing methods and uses thereof
TW202204596A (zh) 2014-06-06 2022-02-01 美商健臻公司 灌注培養方法及其用途
TWI776235B (zh) 2014-06-09 2022-09-01 美商健臻公司 種子罐培養法(seed train processes)及其用途
CA3225136A1 (en) 2014-12-22 2016-06-30 Genzyme Corporation Methods of culturing a mammalian cell
CA3094076A1 (en) * 2018-03-16 2019-09-19 Genzyme Corporation Methods for improving cell viability in a production bioreactor
WO2022035973A1 (en) * 2020-08-12 2022-02-17 Allen Institute Systems, devices, and methods for quality control of cell production using predictive tagging
CN112795531B (zh) * 2021-04-11 2021-08-06 依科赛生物科技(太仓)有限公司 一种cho细胞无血清无蛋白培养基及其用途

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US6458574B1 (en) * 1996-09-12 2002-10-01 Transkaryotic Therapies, Inc. Treatment of a α-galactosidase a deficiency
WO2002050251A2 (en) 2000-12-20 2002-06-27 Bayer Pharmaceuticals Corporation A device and method for seed-train expansion of mammalian cells
AU2002348151A1 (en) 2001-11-05 2003-05-19 Genvec, Inc. Viral vector production methods and compositions
US6953692B2 (en) 2001-12-18 2005-10-11 Bayer Pharmaceuticals Corporation Device and method for seed-train expansion of mammalian cells
US7067279B1 (en) 2002-08-23 2006-06-27 Immunex Corporation Cell culture performance with betaine
US6974681B1 (en) 2002-08-23 2005-12-13 Immunex Corporation Cell culture performance with vanadate
BE1016538A3 (fr) 2004-02-20 2007-01-09 Cesco Bioengineering Co Ltd Appareil et procede pour la preparation et la mise en culture de cellules.
CA2579680A1 (en) 2004-09-16 2006-03-30 Becton, Dickinson And Company Perfusion bioreactor for culturing cells
ES2662589T3 (es) 2005-06-15 2018-04-09 Zhejiang Jinyishengshi Bioengineering Co., Ltd. Recipientes para cultivo en suspensión
WO2006138143A1 (en) 2005-06-15 2006-12-28 Amprotein Corporation Suspension culture vessels
WO2008024769A2 (en) * 2006-08-21 2008-02-28 Raven Biotechnologies, Inc. Intensified perfusion production method
WO2008106515A1 (en) 2007-02-27 2008-09-04 The Board Of Trustees Of The University Of Illinois Insert device for multiwell plate
WO2009034186A2 (en) 2007-09-13 2009-03-19 Helmholtz-Zentrum für Infektionsforschung GmbH Process for cell cultivation
PL2205244T3 (pl) 2007-11-08 2014-01-31 Ambit Biosciences Corp Sposoby podawania N-(5-tert-butylo-izoksazol-3-ilo)-N’-{4-[7-(2-morfolin-4-ylo-etoksy)-imidazo-[2,1-b]-[1,3]-benzotiazol-2-ilo]-fenylo} mocznika do leczenia chorób proliferacyjnych
ES2735173T3 (es) 2007-12-31 2019-12-16 Baxalta GmbH Furina recombinante sustancialmente libre de proteína animal y métodos para producir la misma
US20090233334A1 (en) * 2008-03-11 2009-09-17 Excellgene Sa Cell cultivation and production of recombinant proteins by means of an orbital shake bioreactor system with disposable bags at the 1,500 liter scale
DE102008019691A1 (de) 2008-04-15 2009-10-29 Technische Universität Ilmenau Teilaktives mikrofluidisches System für die 3D-Zellkultivierung sowie Verfahren zu dessen Perfusion
WO2010120514A2 (en) 2009-03-31 2010-10-21 The Trustees Of The University Of Pennsylvania Antigen-binding proteins comprising recombinant protein scaffolds
RS56484B1 (sr) * 2009-11-17 2018-01-31 Squibb & Sons Llc Metode za poboljšanu proizvodnju proteina
US9163089B2 (en) 2011-05-12 2015-10-20 Probiogen Ag Enhancement of protein production yield mediated by a fast shuttling CDC42 GTPase
WO2013116449A1 (en) 2012-02-02 2013-08-08 Corning Incorporated Automatic continuous perfusion cell culture microplate consumables
JP2015517804A (ja) 2012-04-01 2015-06-25 イー・エム・デイー・ミリポア・コーポレイシヨン 細胞培養及び傾斜移動アッセイ方法及び装置
US20140154726A1 (en) 2012-10-23 2014-06-05 Genzyme Corporation Perfusion Culturing Methods and Uses Thereof
CA2901940A1 (en) 2013-02-22 2014-08-28 Genzyme Corporation Microcarrier perfusion culturing methods and uses thereof
AU2014218723B2 (en) 2013-02-22 2019-12-05 Genzyme Corporation Microcarrier perfusion culturing methods and uses thereof
RU2768003C2 (ru) 2013-03-08 2022-03-22 Джензим Корпорейшн Интегрированное непрерывное производство терапевтических белковых лекарственных веществ
WO2014151901A1 (en) 2013-03-14 2014-09-25 Abbvie Inc. Improvement of mammalian cell culture performance through surfactant supplementation of feed media
SG10201707554WA (en) 2013-03-15 2017-11-29 Genzyme Corp High-density cell banking methods
EP3003325A4 (en) 2013-05-29 2017-01-11 Biogen MA Inc. Methods of evaluating cell culture additives
EA031652B1 (ru) 2013-09-16 2019-02-28 Джензим Корпорейшн Способ и система для обработки клеточной культуры
TWI709570B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
ES2709994T3 (es) 2014-06-04 2019-04-22 Amgen Inc Métodos de recolección en cultivos de células de mamífero
TW202204596A (zh) 2014-06-06 2022-02-01 美商健臻公司 灌注培養方法及其用途
TWI776235B (zh) 2014-06-09 2022-09-01 美商健臻公司 種子罐培養法(seed train processes)及其用途
CA3225136A1 (en) 2014-12-22 2016-06-30 Genzyme Corporation Methods of culturing a mammalian cell

Also Published As

Publication number Publication date
SG10202001034PA (en) 2020-04-29
JP2022107000A (ja) 2022-07-20
IL308064A (en) 2023-12-01
TW202106706A (zh) 2021-02-16
CA3225136A1 (en) 2016-06-30
KR20230125102A (ko) 2023-08-28
MX2021007433A (es) 2021-08-05
RU2017126045A3 (pt) 2019-06-24
RU2020101112A (ru) 2020-03-13
RU2017126045A (ru) 2019-01-24
BR112017013423B1 (pt) 2023-04-11
AU2015369809B2 (en) 2022-03-17
TWI741851B (zh) 2021-10-01
WO2016106192A2 (en) 2016-06-30
CA2971861C (en) 2024-02-13
EP3237604A2 (en) 2017-11-01
MX2017008338A (es) 2017-10-19
HK1246345A1 (zh) 2018-09-07
IL253071A0 (en) 2017-08-31
KR102568951B1 (ko) 2023-08-22
AU2022204152A1 (en) 2022-06-30
JP2021019624A (ja) 2021-02-18
IL253071B2 (en) 2024-04-01
US20160177361A1 (en) 2016-06-23
JP7075463B2 (ja) 2022-05-25
US11306341B2 (en) 2022-04-19
SG11201705103WA (en) 2017-07-28
TW201639881A (zh) 2016-11-16
CN107567495A (zh) 2018-01-09
WO2016106192A3 (en) 2016-11-03
JP2024050754A (ja) 2024-04-10
AU2015369809A1 (en) 2017-08-10
JP6843750B2 (ja) 2021-03-17
KR20170090508A (ko) 2017-08-07
US20220145348A1 (en) 2022-05-12
TWI751103B (zh) 2022-01-01
TW202200785A (zh) 2022-01-01
JP2017538435A (ja) 2017-12-28
RU2712746C2 (ru) 2020-01-30
IL253071B1 (en) 2023-12-01
CA2971861A1 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
BR112017013423A2 (pt) métodos de cultura de célula de mamífero .
BR112018008648A2 (pt) métodos de geração de células t a partir de células tronco e métodos imunoterapêuticos ao usar células t
SG10201806217UA (en) Culture medium composition
GB2548740A (en) Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
EA201890137A1 (ru) Среда для культивирования клеток с добавлением таурина и способы применения
MX2020009670A (es) Metodos de cultivo por perfusion y usos de los mismos.
MY171710A (en) Culture medium composition, and method for culturing cell or tissue using said composition
BR112017012335A2 (pt) método, dispositivo e kit para a cultura em massa de células usando uma membrana de poli-imida porosa
BR112016029855A2 (pt) métodos de inoculação de leveduras para fermentação, e métodos e sistemas relacionados à fermentação
MX2021007613A (es) Metodos de establecimiento de bancos de celulas de densidad ultra-alta.
BR112015021189A2 (pt) métodos de banco de células de alta densidade
RS54073B1 (en) STROMAL MATERIAL CELLS
BR112017023624A2 (pt) método de cultivo em pequena escala para células em suspensão
BR112019016672A8 (pt) Método para gerar progenitores de células t
MX2021001981A (es) Metodos para preparar un poloxamero para usar en medio de cultivo celular.
PH12016501038B1 (en) Algae culturing apparatus and algae culturing system
GB2544922A (en) Methods and systems for simulating a hydrocarbon field using a multi-point well connection method
EA201791233A1 (ru) Материал стволовых клеток и способ его получения
BR112018011692A2 (pt) ?método de caracterizar um período de fluxo de combustível misto, e, sistema de controle de combustível para caracterizar um período de fluxo de combustível misto?
MX2016013363A (es) Metodo para aumentar la capacidad de sintesis de biomasa de microorganismos y microorganismos modificados a partir de ellos.
BR112015029440A8 (pt) processos para fermentar substrato gasoso contendo co
Wang A meta-analysis of peer-peer interaction in L2 English speaking assessment
BR112018068586A2 (pt) sistema para identificar um material dentro de um espaço anular de um poço, método para identificar um material dentro de um espaço anular de um poço e meio legível por computador
Teasley et al. " Perceived levels of cultural competence for school social workers: A follow-up study": Corrigendum.
BR112017001252A2 (pt) processos para fermentar e controlar a fermentação de substrato contendo co

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B154 Notification of filing of divisional application [chapter 15.50 patent gazette]

Free format text: O PEDIDO FOI DIVIDIDO NO BR122022026227-9 PROTOCOLO 870220120600 EM 21/12/2022 15:34.

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/12/2015, OBSERVADAS AS CONDICOES LEGAIS